Skip to content

ConverSant R&D

Active Private limited companyfounded 2023active for 3 yearsElenestraat 153, 9620 ZottegemKBO/BCE: BE 0805.558.967

Timeline

10 events since 2023

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 3 days before the deadline
2025
Weakest financial year net €6,622 ▼92.9% The net result drops to €6,622, the lowest from 2023 to 2025.
Liquidity more than doubled current ratio 7.98 The current ratio rises from 3.64 to 7.98. Short-term debt falls from €40,681 to €16,150.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0805558967
Annual accounts 2024 filed PDFmicro format · 2 days before the deadline
2024
Highest result from 2023 to 2025 net €93,099 ▲758% The operating result of €123,982 and the net result of €93,099 are both a record.
Equity above €100,000 equity €108,952 ▲587% With a profit in every financial year since 2023, equity grows to €108,952.
Annual accounts 2023 filed PDFmicro format · 23 days before the deadline
2023
IncorporationFounding capital of €5,000, 5,000 shares · Founded by · appointed as statutory director · published on 11-09-20233 points ▸
  • Founded by
  • The founding capital is €5,000, divided into 5,000 shares
  • appointed as statutory director
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

First establishment Elenestraat 153, Zottegem

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

ConverSant R&D was incorporated on 7 September 2023 as a private limited company by one private individual, with a starting capital of €5,000.12 Since 2023, has served as statutory director.3 Total assets rose from €26,378 in 2023 to €131,724 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 11-09-2023
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2023 and 2025

Next steps